Limitations of Lymph Node Counts as a Measure of Therapy

For several cancers, the number of lymph nodes removed during surgery is associated with survival. Observational studies supporting this association have prompted considerable debate regarding the extent of lymphadenectomy, and in some dieases, absolute lymph node counts have been suggested as a measure of the quality of cancer care. However, for most cancers, lymph node counts may not directly influence survival in a causal manner. In fact, several randomized clinical trials addressing the question in lung, gastric, and pancreatic cancers have not shown more extensive lymph node dissections to be linked with improved survival. Despite this negative evidence, however, lymph node counts have remained a target process in quality initiatives. Misinterpretation of the evidence may be driving some of the pressure to broadly implement more extended lymph node dissections. As a process for more accurate disease staging and as a potential marker for the completeness of surgery, lymph node counts are likely linked to quality, at least indirectly. However, a causal association between lymph node counts (and extented lymphadenectomy) and survival is tenuous and has not been supported by high-level evidence.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Scott M. Gilbert, MD, MS, Department of Urology College of Medicine, University of Florida, 1600 SW Archer Road, N202, Gainesville, FL 32610. E-mail: Scott.Gilbert@urology.ufl.edu

References

  • 1

    SmithDDSchwarzRRSchwarzRE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol2005;23:71147124.

    • Search Google Scholar
    • Export Citation
  • 2

    ChangGJRodriguez-BigasMASkibberJM. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst2007;99:433441.

    • Search Google Scholar
    • Export Citation
  • 3

    KonetyBRJoslynSAO’DonnellMA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program database. J Urol2003;169:946950.

    • Search Google Scholar
    • Export Citation
  • 4

    GajraANewmanNGambleG. Impact of number of lymph nodes sampled on outcome in patients with stage I non-small cell lung cancer. J Clin Oncol2003;21:10291034.

    • Search Google Scholar
    • Export Citation
  • 5

    KoppieTMVickersAJVoraK. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?Cancer2006;107:23682374.

    • Search Google Scholar
    • Export Citation
  • 6

    American College of Surgeons Press Release: National Quality Forum Endorsed Commission on Cancer Measures for Quality of Cancer Care for Breast and Colorectal CancersApril122007. Available at: http://facs.org/cancer/qualitymeasures.html. Accessed July 7 2008.

    • Search Google Scholar
    • Export Citation
  • 7

    WongSLHongJHollenbeckBK. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA2007;298:21492154.

    • Search Google Scholar
    • Export Citation
  • 8

    DonohueJPThornhillJAFosterRS. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965–1989). J Urol1995;153:8589.

    • Search Google Scholar
    • Export Citation
  • 9

    StephensonAJSheinfeldJ. The role of retroperitoneal lymph node dissection in the management of testicular cancer. Urol Oncol2004;22:225233.

    • Search Google Scholar
    • Export Citation
  • 10

    FisherBAndersonSBryantJ. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy with radiation for the treatment of invasive breast cancer. N Engl J Med2002;347:12331241.

    • Search Google Scholar
    • Export Citation
  • 11

    DharNBKleinEAReutherAM. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol2008;179:873878.

    • Search Google Scholar
    • Export Citation
  • 12

    DanielsonHKokkolaAKiviluotoT. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer. Scand J Surg2007;96:3540.

    • Search Google Scholar
    • Export Citation
  • 13

    YonemuraYWuCCFukushimaN. Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: a prospective randomized trial conducted by Asian surgeons. Hepatogastroenterology2006;53:389394.

    • Search Google Scholar
    • Export Citation
  • 14

    BonenkampJJHermansJSasakoM. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med1999;340:908914.

    • Search Google Scholar
    • Export Citation
  • 15

    HartgrinkHHvan der VeldeCJHPutterH. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol2004;22:20692077.

    • Search Google Scholar
    • Export Citation
  • 16

    LeVoyerTESigurdsonERHanlonAL. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of INT-0089. J Clin Oncol2003;21:29122919.

    • Search Google Scholar
    • Export Citation
  • 17

    HerrHWFaulknerJRGrossmanHB. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol2004;22:27812789.

    • Search Google Scholar
    • Export Citation
  • 18

    FisherBSlackNH. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet1970;131:7988.

  • 19

    KellerSMAdakSWagnerH. Mediastinal lymph node dissection improves survival in patients with stage II and stage IIIa non-small cell lung cancer. Ann Thorac Surg2000;70:358366.

    • Search Google Scholar
    • Export Citation
  • 20

    RoukosDHLorenzMEnckeA. Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer based on a new concept: a prospective long-term follow-up study. Surgery1998;123:573578.

    • Search Google Scholar
    • Export Citation
  • 21

    IgakiHTachimoriYKatoH. Improved survival for patients with upper and/or middle mediastinal lymph node metastases of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg2004;239:483490.

    • Search Google Scholar
    • Export Citation
  • 22

    WuYWangSHuangZ. Extent of lymphadenectomy in stage I-IIIA non-small cell lung cancer: a randomized clinical trial. Zhonghua Zhong Liu Za Zhi2001;23:4345.

    • Search Google Scholar
    • Export Citation
  • 23

    IzbickiJRPasslickBPatelK. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer—results of a prospective randomized study. Ann Surg1998;227:138144.

    • Search Google Scholar
    • Export Citation
  • 24

    SugiKNawataKFujitaN. Systematic lymph node dissection for clinically diagnosed peripheral non-small cell cancer less than 2 cm in diameter. World J Surg1998;22:290295.

    • Search Google Scholar
    • Export Citation
  • 25

    PedrazzoliSDi CarloVDionigiR. Standard versus extended lymphadenctomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. A multicenter prospective randomized study. Ann Surg1998;228:508517.

    • Search Google Scholar
    • Export Citation
  • 26

    NimuraYNaginoMKatoH. Regional versus extended lymph node dissection in radical pancreaticoduodenectomy for pancreatic cancer: a multicenter randomized controlled trial. HPB Surg2004;6(Suppl 1):2.

    • Search Google Scholar
    • Export Citation
  • 27

    FarnellMBPearsonRKStarrMG. A prospective randomized trial comparing standard pancreaticoduodenectomy with pancreaticoduodenectomy with extended lymphadenectomy in respectable pancreatic head adenocarcinoma. Surgery2005;138:618630.

    • Search Google Scholar
    • Export Citation
  • 28

    RiallTSCameronJLLillemoeKD. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma—part 3: update on 5-year survival. J Gastrointest Surg2005;9:11911206.

    • Search Google Scholar
    • Export Citation
  • 29

    WongSLJiHHollenbeckBK. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA2007;298:21492154.

  • 30

    SigurdsonER. Lymph node dissection: it is diagnostic or therapeutic?J Clin Oncol2003;21:965967.

  • 31

    WibeAEriksenMTSyseA. Total mesorectal excision for rectal cancer: what can be achieved by a national audit?Colorectal Dis2003;5:471477.

    • Search Google Scholar
    • Export Citation
  • 32

    BirkmeyerJD. Understanding surgeon performance and improving patient outcomes. J Clin Oncol2004;22:27652766.

  • 33

    DeschCEMcNiffKKSchneiderEC. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol2008;26:36313637.

    • Search Google Scholar
    • Export Citation
  • 34

    KonetyBRJoslynSA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol2003;170:17651771.

    • Search Google Scholar
    • Export Citation

Article Information

PubMed

Google Scholar

Related Articles

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 25 25 2
PDF Downloads 2 2 0
EPUB Downloads 0 0 0